Australia markets open in 7 hours 20 minutes

Runben Biotechnology Co., Ltd. (603193.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.64+0.43 (+2.13%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,048,137
1,032,955
856,089
582,147
442,828
Cost of revenue
453,329
450,926
392,152
273,336
210,205
Gross profit
594,808
582,029
463,938
308,811
232,623
Operating expenses
Research development
26,948
25,694
19,513
13,602
10,713
Selling general and administrative
289,030
282,400
240,729
143,898
100,384
Total operating expenses
338,329
330,691
283,062
170,953
121,796
Operating income or loss
256,479
251,338
180,876
137,858
110,827
Interest expense
199.8037
256.3013
428.6021
537.4655
-
Income before tax
285,635
267,926
188,272
141,631
110,242
Income tax expense
45,259
41,898
28,227
20,983
15,529
Income from continuing operations
240,376
226,027
160,045
120,647
94,712
Net income
240,376
226,027
160,045
120,647
94,712
Net income available to common shareholders
240,376
226,027
160,045
120,647
94,712
Basic EPS
0.62
0.64
0.47
0.36
0.31
Diluted EPS
0.62
0.64
0.47
0.36
0.31
Basic average shares
336,784
353,167
340,521
335,131
305,523
Diluted average shares
336,784
353,167
340,521
335,131
305,523